Official recall notice

FDA DrugClass IINotable

Enalapril Maleate Tablets Recall (May 2026)

Product: Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.

Recall date
2026-05-13
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

Verify with the official notice →
Share:

Related Recalls

2026-10-01 · FDA_DRUG
FDA Recall: Greewich: Glutathione Injection
Greewich
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 20 mg per 4 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 15 mg per 3 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 10 mg per 2 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
Enalapril Maleate Tablets Recall (May 2026) | WatchRecall